LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 429

Search options

  1. Article ; Online: Natural Language Processing: Its Potential Role in Clinical Care and Clinical Research.

    Marder, Stephen R

    Schizophrenia bulletin

    2022  Volume 48, Issue 5, Page(s) 958–959

    MeSH term(s) Electronic Health Records ; Humans ; Natural Language Processing
    Language English
    Publishing date 2022-07-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 439173-1
    ISSN 1745-1701 ; 0586-7614
    ISSN (online) 1745-1701
    ISSN 0586-7614
    DOI 10.1093/schbul/sbac092
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Changing the Face of Schizophrenia.

    Marder, Stephen R

    The American journal of psychiatry

    2021  Volume 178, Issue 7, Page(s) 584–585

    MeSH term(s) Humans ; Psychotic Disorders ; Schizophrenia/diagnosis ; Schizophrenic Psychology
    Language English
    Publishing date 2021-07-16
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 280045-7
    ISSN 1535-7228 ; 0002-953X
    ISSN (online) 1535-7228
    ISSN 0002-953X
    DOI 10.1176/appi.ajp.2021.21050480
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatments.

    Marder, Stephen R / Umbricht, Daniel

    Schizophrenia research

    2023  Volume 258, Page(s) 71–77

    Abstract: The negative symptoms of schizophrenia, which often appear earlier than any other symptom, are prominent and clinically relevant in the majority of patients. As a result, interest in their treatment has increased. Patients who exhibit significant ... ...

    Abstract The negative symptoms of schizophrenia, which often appear earlier than any other symptom, are prominent and clinically relevant in the majority of patients. As a result, interest in their treatment has increased. Patients who exhibit significant negative symptoms have worse functional outcomes than those without, resulting in impairments in occupational, household, and recreational functioning, as well as difficulties in relationships. Yet treatment with currently available medications does not lead to any significant improvements in this core component of schizophrenia. An increased understanding of the pathophysiology underlying negative symptoms and the discovery of novel treatments that do not directly target dopamine offer the potential to develop therapies that may reduce negative symptoms and increase quality of life for patients. The current article will discuss the impact of negative symptoms, outline current measurement tools for the assessment of negative symptoms, and examine how these measures may be improved. Insights into the neural circuitry underlying negative symptoms will be discussed, and promising targets for the development of effective treatments for these symptoms will be identified. As more prospective, large-scale, randomized studies focus on the effects of treatments on negative symptoms, progress in this area is foreseeable. However, improvements in clinical assessment instruments, a better understanding of the underlying neural mechanisms, development of novel treatments with varied targets, and a greater focus on personalized treatment are all important to produce significant benefits for patients with negative symptoms of schizophrenia.
    MeSH term(s) Humans ; Schizophrenia/diagnosis ; Schizophrenia/drug therapy ; Quality of Life ; Prospective Studies ; Treatment Outcome
    Language English
    Publishing date 2023-07-28
    Publishing country Netherlands
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 639422-x
    ISSN 1573-2509 ; 0920-9964
    ISSN (online) 1573-2509
    ISSN 0920-9964
    DOI 10.1016/j.schres.2023.07.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Reductive dimerization of benzothiazolium salts.

    Shaikh, Aijaz / Sahoo, Satyajit / Marder, Seth R / Barlow, Stephen / Mohapatra, Swagat K

    Organic & biomolecular chemistry

    2024  Volume 22, Issue 10, Page(s) 2115–2123

    Abstract: Three different types of reaction products were obtained from the reduction of 2-substituted 3-methylbenzothiazolium salts using Na : Hg (1 wt%). Depending on the 2-substituents, two types of dimeric compounds were obtained: the 2-cyclohexyl-, 2-phenyl-, ...

    Abstract Three different types of reaction products were obtained from the reduction of 2-substituted 3-methylbenzothiazolium salts using Na : Hg (1 wt%). Depending on the 2-substituents, two types of dimeric compounds were obtained: the 2-cyclohexyl-, 2-phenyl-, and 2-(
    Language English
    Publishing date 2024-03-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 2097583-1
    ISSN 1477-0539 ; 1477-0520
    ISSN (online) 1477-0539
    ISSN 1477-0520
    DOI 10.1039/d3ob01871g
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Stigma-Personal Views.

    Saks, Elyn R / Marder, Stephen R

    Schizophrenia bulletin

    2020  Volume 47, Issue 1, Page(s) 1–2

    MeSH term(s) Humans ; Personal Narratives as Topic ; Psychotic Disorders/therapy ; Schizophrenia/therapy ; Social Stigma
    Language English
    Publishing date 2020-09-22
    Publishing country United States
    Document type Editorial
    ZDB-ID 439173-1
    ISSN 1745-1701 ; 0586-7614
    ISSN (online) 1745-1701
    ISSN 0586-7614
    DOI 10.1093/schbul/sbaa135
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Organometallic and Organic Dimers: Moderately Air-Stable, Yet Highly Reducing, n-Dopants.

    Mohapatra, Swagat K / Marder, Seth R / Barlow, Stephen

    Accounts of chemical research

    2022  Volume 55, Issue 3, Page(s) 319–332

    Abstract: ConspectusElectrical doping using redox-active molecules can increase the conductivity of organic semiconductors and lower charge-carrier injection and extraction barriers; it has application in devices such as organic and perovskite light-emitting ... ...

    Abstract ConspectusElectrical doping using redox-active molecules can increase the conductivity of organic semiconductors and lower charge-carrier injection and extraction barriers; it has application in devices such as organic and perovskite light-emitting diodes, organic and perovskite photovoltaic cells, field-effect transistors, and thermoelectric devices. Simple one-electron reductants that can act as n-dopants for a wide range of useful semiconductors must necessarily have low ionization energies and are, thus, highly sensitive toward ambient conditions, leading to challenges in their storage and handling. A number of approaches to this challenge have been developed, in which the highly reducing species is generated from a precursor or in which electron transfer is coupled in some way to a chemical reaction. Many of these approaches are relatively limited in applicability because of processing constraints, limited dopant strength, or the formation of side products.This Account discusses our work to develop relatively stable, yet highly reducing, n-dopants based on the dimers formed by some 19-electron organometallic complexes and by some organic radicals. These dimers are sufficiently inert that they can be briefly handled as solids in air but react with acceptors to release two electrons and to form two equivalents of stable monomeric cations, without formation of unwanted side products. We first discuss syntheses of such dimers, both previously reported and our own. We next turn to discuss their thermodynamic redox potentials, which depend on both the oxidation potential of the highly reducing odd-electron monomers and on the free energies of dissociation of the dimers; because trends in both these quantities depend on the monomer stability, they often more-or-less cancel, resulting in effective redox potentials for a number of the organometallic dimers that are approximately -2.0 V vs ferrocenium/ferrocene. However, variations in the dimer oxidation potential and the dissociation energies determine the mechanism through which a dimer reacts with a given acceptor in solution: in all cases dimer-to-acceptor electron transfer is followed by dimer cation cleavage and a subsequent second electron transfer from the neutral monomer to the acceptor, but examples with weak central bonds can also react through endergonic cleavage of the neutral dimer, followed by electron-transfer reactions between the resulting monomers and the acceptor. We, then, discuss the use of these dimers to dope a wide range of semiconductors through both vacuum and solution processing. In particular, we highlight the role of photoactivation in extending the reach of one of these dopants, enabling successful doping of a low-electron-affinity electron-transport material in an organic light-emitting diode. Finally, we suggest future directions for research using dimeric dopants.
    Language English
    Publishing date 2022-01-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1483291-4
    ISSN 1520-4898 ; 0001-4842
    ISSN (online) 1520-4898
    ISSN 0001-4842
    DOI 10.1021/acs.accounts.1c00612
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Alpha-7 nicotinic agonist improves cognition in schizophrenia.

    Marder, Stephen R

    Evidence-based mental health

    2016  Volume 19, Issue 2, Page(s) 60

    MeSH term(s) Cognition ; Humans ; Nicotinic Agonists/therapeutic use ; Schizophrenia/drug therapy
    Chemical Substances Nicotinic Agonists
    Language English
    Publishing date 2016-02-12
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 2009065-1
    ISSN 1468-960X ; 1362-0347
    ISSN (online) 1468-960X
    ISSN 1362-0347
    DOI 10.1136/eb-2015-102214
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Community Evidence of Clozapine's Effectiveness.

    Marder, Stephen R

    The American journal of psychiatry

    2016  Volume 173, Issue 2, Page(s) 103–104

    MeSH term(s) Antipsychotic Agents/therapeutic use ; Clozapine/therapeutic use ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Mental Health Services/utilization ; Psychotic Disorders/drug therapy ; Schizophrenia/drug therapy
    Chemical Substances Antipsychotic Agents ; Clozapine (J60AR2IKIC)
    Language English
    Publishing date 2016-02-01
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 280045-7
    ISSN 1535-7228 ; 0002-953X
    ISSN (online) 1535-7228
    ISSN 0002-953X
    DOI 10.1176/appi.ajp.2015.15111466
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Book ; Conference proceedings: Is D 2 antagonism required for antipsychotic activity?

    Marder, Stephen R.

    proceedings of a conference held in February 1999 [in Washington, DC]

    (Neuropsychopharmacology ; 21,S6 = Spec. suppl.)

    1999  

    Author's details guest ed.: Stephen R. Marder
    Series title Neuropsychopharmacology ; 21,S6 = Spec. suppl.
    Collection
    Language English
    Size S. S118 - S218 : Ill., graph. Darst.
    Publisher Elsevier
    Publishing place New York, NY
    Publishing country United States
    Document type Book ; Conference proceedings
    HBZ-ID HT012769640
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  10. Article ; Online: Schizophrenia.

    Marder, Stephen R / Cannon, Tyrone D

    The New England journal of medicine

    2019  Volume 381, Issue 18, Page(s) 1753–1761

    MeSH term(s) Antipsychotic Agents/adverse effects ; Antipsychotic Agents/therapeutic use ; Combined Modality Therapy ; Diagnostic and Statistical Manual of Mental Disorders ; Dopamine/metabolism ; Humans ; Models, Neurological ; Psychotherapy ; Schizophrenia/diagnosis ; Schizophrenia/etiology ; Schizophrenia/metabolism ; Schizophrenia/therapy
    Chemical Substances Antipsychotic Agents ; Dopamine (VTD58H1Z2X)
    Language English
    Publishing date 2019-11-17
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMra1808803
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top